{
    "2018-10-16": [
        [
            {
                "time": "2018-10",
                "original_text": "2018年10月疫苗行业季报(2018Q3)：五联苗及四价流感获批签发 4价和9价HPV供不应求",
                "features": {
                    "keywords": [
                        "疫苗",
                        "五联苗",
                        "四价流感",
                        "9价HPV",
                        "供不应求",
                        "获批签发"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10",
                "original_text": "[买入评级]医药生物行业跟踪：新上市疫苗放量 关注流感疫苗供需缺口",
                "features": {
                    "keywords": [
                        "买入评级",
                        "医药生物",
                        "新上市疫苗",
                        "流感疫苗",
                        "供需缺口"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}